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Pulmonary Embolism
Kira Robison, RN
OBerbein University, Westerville, Ohio
Pathophysiological Process

Introduc6on
Deep vein thrombosis (DVT) and
Pulmonary Embolism (PE) are often
under diagnosed, but are serious
medical conditions that can be
prevented. Specigically, “a
pulmonary embolism is a blockage
in the pulmonary artery, which
supplies the blood to the lungs. It is
one of the most common
cardiovascular diseases in the
United States”(Crosta, 2018). Due to
this very reason, the
pathophysiological topic of acute
pulmonary embolism was chosen to
be researched so that a more
thorough understanding of the topic
could be reached.
Acute pulmonary embolism is a
life-threatening diagnosis that can
present with a multitude of
nonspecigic symptoms and can
quickly become a life-threatening
diagnosis. Clinicians must approach
suspected cases of PE with a
heightened awareness and follow
evidence-based recommendations
for the diagnosis and treatment of
acute PE (Morici, 2014). Pulmonary
embolism is among the most
treatable and preventable causes of
death in the United States (Minges et
al., 2015).
There are many risk factors such
as genetics, obesity, birth control,
pregnancy, smoking, recent
surgeries, prolonged bed rest and
more that will increase an
individuals chances of developing a
DVT/PE. When a patient presents
with any signs and symptoms of a
possible PE, such as shortness of
breath, chest discomfort,
hemoptysis, leg swelling/discomfort,
etc. it is the clinicians responsibility
to take the proper steps in
diagnosing and treating the possible
pulmonary embolism.
There are many aspects of a
patients care that must be
considered by the clinician when
taking care of a patient with a PE.
The articles used throughout this
presentation will help to provide
additional resources and education
to those individuals looking to
increase their knowledge base in
regards to caring for a patient with a
pulmonary embolism.

Acute PE caused by thrombo-emboli may be spontaneous and often originates in the
deep venous system of the lower extremities, upper extremities, right side of the heart, or
pelvis (Morici, 2014). There are several factors that can increase a patient’s susceptibility to
thrombus formation. Virchow triad (stasis, vascular wall injury, and hypercoagulability) can
be used to assess the patient’s risk of developing thrombi (Morici, 2014). Stasis is often
considered the most prominent factor, which, in conjunction with either vessel damage or
hypercoagulability, can lead to clot formation; stasis can present in a variety of settings,
including immobilization, chronic venous insufgiciency, paresis secondary to stroke or other
causes, and varicose veins (Morici, 2014).
Once deep vein thrombosis develops, clots may dislodge and travel through the venous
system and the right side of the heart to lodge in the pulmonary arteries, where they
partially or completely occlude one or more vessels (Tapson, 2018). The outcome depends
on the size and number of emboli, the underlying condition of the lungs, how well the right
ventricle is functioning, and the ability of the patients body to dissolve the clot(s).
Small emboli may have no acute physiologic effects and may begin to lyse immediately
and resolve within hours or days. Larger emboli can cause a reglex increase in ventilation
(tachypnea), hypoxemia due to ventilation/perfusion (V/Q) mismatch, and low mixed
venous oxygen content as a result of low cardiac output, atelectasis due to alveolar
hypocapnia and abnormalities in surfactant, and an increase in pulmonary vascular
resistance caused by mechanical obstruction and vasoconstriction (Tapson, 2018). When
large emboli occlude major pulmonary arteries, or when many small emboli occlude > 50%
of the more distal vessels, RV pressure increases, which may lead to acute RV failure, shock,
or sudden death. The risk of death depends on the degree and rate of rise of right-sided
pressures and on the patient’s underlying cardiopulmonary status (Tapson, 2018).

Signs and Symptoms

Risk Factors

•

Shortness of breath (dyspnea)

•

Genetic and acquired tendencies

•

Chest discomfort

•

Pregnancy; use of birth control pills

•

Coughing up blood (hemoptysis)

•

Palpitations

•

Obesity

•

Dizziness and fainting

•

Smoking

•

Leg swelling and discomfort

•

Cancer

•

Increased respiratory rate (tachypnea)

•

Medical illnesses including hear

•

Shortness of breath when lying glat

disease, lung disease, and kidney

(orthopnea)

disease

or hormone therapy

•

Increased heart rate (tachycardia)

•

Older age

•

Decreased breath sounds

•

Recent surgery, trauma,

•

Jugular Venous Distention (JVD)

Case Study

• Presentation
Harry is an 81 year-old man who presents to your ED with a 3 day history of breathlessness. He
reports coughing up fresh blood and a sharp pain on the left side of his chest on taking a deep
breath.
• Question
You believe Harry has symptoms of a suspected PE. What would you do next?
• Answer:
Carry out an assessment of his general medical history, a physical examination and a chest xray to exclude other causes. On examination his vitals are RR 20 breaths per minute, BP
145/90 mmHg, HR 72 beats per min, Temp 37.5c, SpO2 92% on RA. Upon auscultation of his
lungs you hear crackles at the left base. Chest x-ray shows a small left-sided pleural effusion.
Upon further questioning you find out that Harry has been in bed for the part 4 days because he
felt unwell.
• Question
You still suspect pulmonary embolism. What would you do next?
• Answer
Offer Harry a D-dimer test.
• Question
Harry’s D-dimer is positive. What would you do next?
• Answer
Offer an immediate CPTA. On this occasion CTPA is available for Harry immediately. The
consultant in charge assesses Harry and deems him stable for transfer for CTPA. The CT
department agree to accept him for CTPA and he is transferred with medical escort.
• Question
Harry’s CTPA is positive for PE and he remains hemodynamically unstable. What would you do
next?

Nursing Implica6ons

As an advanced practice nurse, it is important to know the signs and symptoms
of pulmonary embolism (PE). Due to the fact that the signs and symptoms
associated with PE can be nonspecigic, the condition can be a diagnostic challenge.
Often a patient may present atypically or have none of the preceding symptoms;
because of the risk of sudden death from acute PE, clinicians should have a
heightened awareness of PE when assessing patients (Morici, 2014).
Being proactive and preventing a DVT/PE from ever developing is a key
responsibility of clinicians. Bedbound patients and patients undergoing surgical,
especially orthopedic, procedures can be identigied as “high risk” before a thrombus
ever forms. Preventive measures include low-dose unfractionated heparin, low
molecular weight heparin, warfarin, fondaparinux, oral anticoagulants
(rivaroxaban, apixaban, dabigatran), compression devices, and elastic compression
stockings (Tapson, 2018). Choice of drug or device depends on various factors,
including the patient population, the perceived risk, contraindications, relative
costs, and ease of use.
If a PE develops in the acute setting, the initial treatment should be focused on
stabilizing the patient. Provide supplemental oxygen to ensure adequate
oxygenation, and monitor pulse oximetry continually, with a reasonable goal of
92%. The mainstay therapy for PE is anticoagulation. Treatment options include
unfractionated heparin, fondaparinux, warfarin, and rivaroxaban. The American
College of Chest Physicians (ACCP) suggests LMWH as the initial anticoagulant;
however, treatment should be individualized based on the patient's characteristics
and comorbidities (Morici, 2014).

• Answer
Diagnose PE and treat as soon as possible. Because of Harry’s hemodynamic instability start
unfractionated heparin and consider offering systematic thrombolytic therapy. In considering
systematic thrombolytic therapy, expert clinical opinion advises provision of adequate
monitoring facilities. Harry agrees to being treated with systemic thrombolytic therapy and
appropriate facilities are made immediately available to safely administer and monitor
systematic thrombolytic therapy. Following the acute management phase Harry is stabilized and
continues on UFH until the international normalized ratio (INR) (adjusted by a VKA) is 2 or
above for at least 24 hours.
("Venous Thromboembolic Diseases," 2012)

("Quick Facts," n.d.) National Blood Clot Alliance

References
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Conclusion
• Acute PE is a common and potentially devastating medical condition.
• In an acute or ambulatory care setting, providers will likely be faced with patients who present with
signs and symptoms indicative of PE.
• Clinical suspicion and congirmatory diagnosis are essential because in most patients who die from
acute PE, PE is not even suspected.
• Due to the poor specigicity of these presenting cases, clinicians must be vigilant about suspecting PE
in patients at an increased risk.
• Prompt triage, imaging, and treatment can improve morbidity and mortality signigicantly.
• Discovering the underlying pathology can assist providers in determining the length of therapy and
need for continued treatment and prevention.
• Because anticoagulation improves survival, patients with PE should be considered for thrombolytic
therapy or embolectomy.
• Recent pharmaceutical and technological advances have added to the treatments available for PE
and will continue to evolve as scientigic research continues, with a goal of further improving

(Merrigan, Piazza, & Lynm, 2013) How Pulmonary Embolism occurs

• The risk of PE increases with age
• The risk of PE is high for individuals who have
had a blood clot in the leg/arm
• In rare cases, a PE can be caused by amniotic
gluid
• In about 25% of people who experience a PE,
the girst “symptom” is sudden death
• 10% to 30% of people affected by DVT/PE will
die within one month of diagnosis
• One-third (about 33%) of people with DVT/PE
will die within one month of diagnosis
• Acute PE’s affect 300,000 to 600,000 people in
the United States annually

(Zagaria, 2009) Factors Increasing Risk for Embolism

hospitalization, or prolonged bed rest

(Kerkar, 2018) PrevenWon of Pulmonary Embolism

Facts/Sta6s6cs

identigication, diagnosis, and treatment of acute PE.
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